Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
The EMBO Journal
|
May 15, 1996
Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation
P Rodriguez-Viciana, P H Warne, B Vanhaesebroeck, et al.
FEBS Letters
|
February 26, 1990
Cytotoxic activity of tumor necrosis factor is inhibited by amiloride derivatives without involvement of the Na+/H+ antiporter
B Vanhaesebroeck, E J Cragoe, J Pouysségur, et al.
European Journal of Biochemistry
|
January 30, 1991
Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se
P Suffys, R Beyaert, D De Valck, et al.
The Journal of Biological Chemistry
|
March 15, 1992
Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation
K Schulze-Osthoff, A C Bakker, B Vanhaesebroeck, et al.
Oncogene
|
May 17, 2006
A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16
C Billottet, V L Grandage, R E Gale, et al.
Developments in Biological Standardization
|
January 1, 1988
TNF: its potential as an antitumour agent
W Fiers, R Beyaert, P Brouckaert, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1992
Expression of an exogenous tumor necrosis factor (TNF) gene in TNF-sensitive cell lines confers resistance to TNF-mediated cell lysis
B Vanhaesebroeck, E Decoster, X Van Ostade, et al.
Journal of Cell Science
|
January 14, 2000
The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling
R Hooshmand-Rad, L Hájková, P Klint, et al.
The Journal of Biological Chemistry
|
March 7, 1998
Induction of unresponsiveness to tumor necrosis factor (TNF) after autocrine TNF expression requires TNF membrane retention
E Decoster, B Vanhaesebroeck, E Boone, et al.
Cancer Research
|
May 1, 1991
Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line
B Vanhaesebroeck, S Van Bladel, A Lenaerts, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
The EMBO Journal
|
May 15, 1996
Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation
P Rodriguez-Viciana, P H Warne, B Vanhaesebroeck, et al.
FEBS Letters
|
February 26, 1990
Cytotoxic activity of tumor necrosis factor is inhibited by amiloride derivatives without involvement of the Na+/H+ antiporter
B Vanhaesebroeck, E J Cragoe, J Pouysségur, et al.
European Journal of Biochemistry
|
January 30, 1991
Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se
P Suffys, R Beyaert, D De Valck, et al.
The Journal of Biological Chemistry
|
March 15, 1992
Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation
K Schulze-Osthoff, A C Bakker, B Vanhaesebroeck, et al.
Oncogene
|
May 17, 2006
A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16
C Billottet, V L Grandage, R E Gale, et al.
Developments in Biological Standardization
|
January 1, 1988
TNF: its potential as an antitumour agent
W Fiers, R Beyaert, P Brouckaert, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1992
Expression of an exogenous tumor necrosis factor (TNF) gene in TNF-sensitive cell lines confers resistance to TNF-mediated cell lysis
B Vanhaesebroeck, E Decoster, X Van Ostade, et al.
Journal of Cell Science
|
January 14, 2000
The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling
R Hooshmand-Rad, L Hájková, P Klint, et al.
The Journal of Biological Chemistry
|
March 7, 1998
Induction of unresponsiveness to tumor necrosis factor (TNF) after autocrine TNF expression requires TNF membrane retention
E Decoster, B Vanhaesebroeck, E Boone, et al.
Cancer Research
|
May 1, 1991
Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line
B Vanhaesebroeck, S Van Bladel, A Lenaerts, et al.
Page
of 5